New Therapeutic Directions for Advanced Pancreatic Cancer: Targeting the Epidermal Growth Factor and Vascular Endothelial Growth Factor Pathways

Learning Objectives After completing this course, the reader will be able to: Evaluate the existing chemotherapeutic options for advanced pancreatic cancer. Interpret data from trials of HER‐1/EGFR‐ and VEGFR‐targeted agents in advanced pancreatic cancer. Take advantage of the potential of biomarker...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2008-03, Vol.13 (3), p.289-298
Hauptverfasser:	Burris, Howard, Rocha‐Lima, Caio
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic - therapeutic use Benzenesulfonates - therapeutic use Bevacizumab Cetuximab Chemotherapy Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Erlotinib Erlotinib Hydrochloride Humans Niacinamide - analogs & derivatives Pancreatic cancer Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Phenylurea Compounds Pyridines - therapeutic use Quinazolines - therapeutic use Receptor, Epidermal Growth Factor - antagonists & inhibitors Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors Signal Transduction - drug effects Sorafenib
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!